Reclaim Deep Brain Stimulation (DBS) Therapy for Obsessive Compulsive Disorder
Purpose of Study: The Food and Drug Administration (FDA) gave approval of the Humanitarian Device Exemption (HDE) a Humanitarian use device for Medtronic Reclaim Therapy to Medtronic, Inc. (HDE# H050003). Medtronic Reclaim Deep Brain Stimulation (DBS) Therapy for Obsessive Compulsive Disorder (OCD) delivers electrical stimulation to areas in the brain to help control symptoms of treatment resistant OCD. The Medtronic Reclaim DBS Therapy is indicated for bilateral stimulation of a specific region of the brain (anterior limb of the internal capsule), in conjunction with OCD medications for treatment of chronic, severe, treatment resistant OCD in adult patients who have failed at least three selective serotonin reuptake inhibitor medications. DBS is used as an alternative to anterior capsulotomy (different type of surgery) that is indicated for this condition.
Principal Investigator: Milind Deogaonkar, MD
Contact: Thomas Geist